Sanofi Files 6-K Report on April 15, 2026

Ticker: SNY · Form: 6-K · Filed: Apr 15, 2026

Sentiment: neutral

Topics: foreign-issuer, sec-filing, disclosure

TL;DR

Sanofi dropped a 6-K filing on 4/15/26 - check the exhibits for deets.

AI Summary

Sanofi, a foreign issuer, filed a 6-K report on April 15, 2026. The filing includes several documents, such as the 6-K itself and exhibits EX-99.1 and EX-99.2, along with graphic files. The company's business and mailing address are both listed as 46 Avenue de la Grande Armée, Paris, France.

Why It Matters

This filing provides an update from Sanofi, a major pharmaceutical company, which could contain important information for investors and stakeholders regarding its operations or disclosures.

Risk Assessment

Risk Level: low — A 6-K filing is typically a routine report for foreign issuers and does not inherently signal significant risk.

Key Numbers

Key Players & Entities

FAQ

What is the primary purpose of a Form 6-K filing?

A Form 6-K is a report of foreign issuer required by SEC rules, used to furnish information which the issuer makes or is required to make public pursuant to the laws of its home country.

What are the key documents included in this filing?

The filing includes the 6-K report itself (d133868d6k.htm), two exhibits (EX-99.1 and EX-99.2), and two graphic files.

When was this specific 6-K filing accepted by the SEC?

This filing was accepted on April 15, 2026, at 06:57:09.

Where is Sanofi's business located?

Sanofi's business address is listed as 46 Avenue de la Grande Armée, Paris I0 75017.

What is Sanofi's CIK number?

Sanofi's CIK number is 0001121404.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on April 15, 2026 regarding Sanofi (SNY).

View full filing on EDGAR

View on Read The Filing